SIBN · SI-BONE reported Q3 2026 revenue of $55.7M (up 14.5% YoY) and a net…

SI-BONE reported Q3 2026 revenue of $55.7M (up 14.5% YoY) and a net loss of $0.08 per share, beating consensus estimates of $-0.13 EPS and $55.3M revenue. The company reaffirmed its full-year revenue guidance of $231M-$233M and narrowed operating expense growth expectations to ~10.5%, while highlighting strong procedure volume growth and a new product clearance.

• Q3 2026 revenue of $55.7M, up 14.5% YoY, above consensus of $55.3M
• GAAP net loss of $0.08 per share, improving from a loss of $0.11 per share in Q3 2025, beating consensus of $-0.13
• Positive adjusted EBITDA of $3.0M, up 32.4% YoY
• Positive cash from operations of $5.9M, up 154.4% YoY